Formations of, Acquisitions by, and Mergers of Savings and Loan Holding Companies

CourtFederal Reserve System
Citation86 FR 16599
Published date30 March 2021
Record Number2021-06462
16599
Federal Register / Vol. 86, No. 59 / Tuesday, March 30, 2021 / Notices
standards enumerated in paragraph 7 of
the Act.
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington DC 20551–0001, not later
than April 14, 2021.
A. Federal Reserve Bank of Richmond
(Adam M. Drimer, Assistant Vice
President) 701 East Byrd Street,
Richmond, Virginia 23219. Comments
can also be sent electronically to or
Comments.applications@rich.frb.org:
1. Jacob S. Fisher, Salisbury, North
Carolina; to retain voting shares of F&M
Financial Corporation (F&M), Granite
Quarry, North Carolina, by continuing
to serve as sole general partner of Fisher
Woodside LP, Salisbury, North Carolina,
which owns F&M, and thereby
indirectly owns Farmers and Merchants
Bank, Granite Quarry, North Carolina.
Board of Governors of the Federal Reserve
System, March 25, 2021.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
[FR Doc. 2021–06541 Filed 3–29–21; 8:45 am]
BILLING CODE P
FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and
Mergers of Savings and Loan Holding
Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Home Owners’ Loan Act
(12 U.S.C. 1461 et seq.) (HOLA),
Regulation LL (12 CFR part 238), and
Regulation MM (12 CFR part 239), and
all other applicable statutes and
regulations to become a savings and
loan holding company and/or to acquire
the assets or the ownership of, control
of, or the power to vote shares of a
savings association.
The public portions of the
applications listed below, as well as
other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank(s) indicated below and at
the offices of the Board of Governors.
This information may also be obtained
on an expedited basis, upon request, by
contacting the appropriate Federal
Reserve Bank and from the Board’s
Freedom of Information Office at
https://www.federalreserve.gov/foia/
request.htm. Interested persons may
express their views in writing on
whether the proposed transaction
complies with the standards
enumerated in the HOLA (12 U.S.C.
1467a(e)).
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington DC 20551–0001, not later
than April 28, 2021.
A. Federal Reserve Bank of Atlanta
(Kathryn Haney, Assistant Vice
President) 1000 Peachtree Street NE,
Atlanta, Georgia 30309. Comments can
also be sent electronically to
Applications.Comments@atl.frb.org:
1. TC Bancshares, Inc., Thomasville,
Georgia; to become a savings and loan
holding company by acquiring TC
Federal Bank, Thomasville, Georgia, in
connection with the mutual-to-stock
conversion of TC Federal Bank.
Board of Governors of the Federal Reserve
System, March 24, 2021.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
[FR Doc. 2021–06462 Filed 3–29–21; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–3411–N]
Medicare, Medicaid, and CLIA
Programs; Clinical Laboratory
Improvement Amendments of 1988
Exemption of Permit-Holding
Laboratories in the State of New York
AGENCY
: Centers for Medicare &
Medicaid Services (CMS), Department
of Health and Human Services (HHS).
ACTION
: Notice.
SUMMARY
: This notice announces that
laboratories located in and licensed by
the State of New York that possess a
valid permit under the New York State
Public Health Law are exempt from the
requirements of the Clinical Laboratory
Improvement Amendments of 1988
(CLIA) for a period of 6 years.
DATES
: The exemption granted by this
notice is effective from March 26, 2021
to March 26, 2027.
FOR FURTHER INFORMATION CONTACT
:
Penny Keller, (410) 786–2035.
SUPPLEMENTARY INFORMATION
:
I. Background and Legislative
Authority
Section 353 of the Public Health
Service Act (PHSA), as amended by the
Clinical Laboratory Improvement
Amendments of 1988 (CLIA) (Pub. L.
100–578, enacted on October 31, 1988),
generally provides that no laboratory
may perform tests on human specimens
for the diagnosis, prevention, or
treatment of any disease or impairment
of, or assessment of the health of,
human beings unless it has a certificate
to perform that category of tests issued
by the Secretary of the Department of
Health and Human Services (HHS).
Under section 1861(s)(17)(A) of the
Social Security Act (the Act), the
Medicare program will only pay for
laboratory services if the laboratory has
a CLIA certificate. Section 1902(a)(9)(C)
of the Act generally requires that state
Medicaid plans pay only for laboratory
services furnished by CLIA-certified
laboratories. Thus, although subject to
specified exemptions and exceptions,
laboratories generally must have a
current and valid CLIA certificate to test
human specimens for the purposes
noted above to be eligible for payment
for those tests from the Medicare or
Medicaid programs. Regulations
implementing section 353 of the PHSA
are contained in 42 CFR part 493.
Section 353(p) of the PHSA provides
for the exemption of laboratories from
CLIA requirements in states that enact
legal requirements that are equal to or
more stringent than CLIA’s statutory
and regulatory requirements. Section
353(p) of the PHSA is implemented in
subpart E of our regulations at 42 CFR
part 493. Sections 493.551 and 493.553
provide that we may exempt from CLIA
requirements, for a period not to exceed
6 years, all state-licensed or -approved
laboratories in a state if the state
licensure program meets the specified
conditions. Section 493.559 provides
that we will publish a notice in the
Federal Register when we grant an
exemption to an approved state
licensure program. It also provides that
the notice will include the following:
The basis for granting the
exemption.
A description of how the state’s
laboratory requirements are equal to or
more stringent than those of CLIA.
The term of approval, not to exceed
6 years.
A. State of New York’s Application for
CLIA Exemption of Its Laboratories
The State of New York has applied for
exemption of its Clinical Laboratory
Evaluation Program (CLEP) permit-
holding laboratories from CLIA program
requirements. New York State law is
generally applicable to all clinical
laboratories operating within the State
of New York except those operated by
the Federal Government and those
operated by a licensed physician,
VerDate Sep<11>2014 17:59 Mar 29, 2021 Jkt 253001 PO 00000 Frm 00025 Fmt 4703 Sfmt 4703 E:\FR\FM\30MRN1.SGM 30MRN1
jbell on DSKJLSW7X2PROD with NOTICES

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT